Exosens SA (EXENS) Stock Price & News

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	108.20M	140.40M	126.53M	126.53M
Cost of goods sold	-	-	47.50M	47.50M
Cost of revenue	-	-	47.50M	47.50M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	-	39.64M	39.64M
Operating expense	-	-	62.69M	62.69M
Total operating expenses	-	-	110.19M	110.19M
Operating income	-	-	16.35M	16.35M
Other non operating income	-	-	-192.00K	-192.00K
EBT including unusual items	-	-	12.60M	12.60M
EBT excluding unusual items	-	-	13.33M	13.33M
Income tax expense	-	-	4.93M	4.93M
Effective tax rate	-	-	39.15%	39.15%
Other operating expenses	-	-	-70.00K	-70.00K
Net income	-	-	7.67M	7.67M
Net profit margin	-	-	6.06%	6.06%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-3.16M	-3.16M
Net interest expenses	-	-	-3.16M	-3.16M
Depreciation and amortization charges	-	-	23.12M	23.12M
EBITDA	-	-	22.28M	22.28M
Gain or loss from assets sale	-	-	-	-

Ask anything